Literature DB >> 24477856

Correlations between peripheral blood Coxiella burnetii DNA load, interleukin-6 levels, and C-reactive protein levels in patients with acute Q fever.

M N T Kremers1, R Janssen, C C H Wielders, L M Kampschreur, P M Schneeberger, P M Netten, A de Klerk, H M Hodemaekers, M H A Hermans, D W Notermans, P C Wever.   

Abstract

From 2007 to 2010, the Netherlands experienced the largest reported Q fever outbreak, with >4,000 notified cases. We showed previously that C-reactive protein is the only traditional infection marker reflecting disease activity in acute Q fever. Interleukin-6 is the principal inducer of C-reactive protein. We questioned whether increased C-reactive protein levels in acute Q fever patients coincide with increased interleukin-6 levels and if these levels correlate with the Coxiella burnetii DNA load in serum. In addition, we studied their correlation with disease severity, expressed by hospital admission and the development of fatigue. Interleukin-6 and C-reactive protein levels were analyzed in sera from 102 patients diagnosed with seronegative PCR-positive acute Q fever. Significant but weak negative correlations were observed between bacterial DNA loads expressed as cycle threshold values and interleukin-6 and C-reactive protein levels, while a significant moderate-strong positive correlation was present between interleukin-6 and C-reactive protein levels. Furthermore, significantly higher interleukin-6 and C-reactive protein levels were observed in hospitalized acute Q fever patients in comparison to those in nonhospitalized patients, while bacterial DNA loads were the same in the two groups. No marker was prognostic for the development of fatigue. In conclusion, the correlation between interleukin-6 and C-reactive protein levels in acute Q fever patients points to an immune activation pathway in which interleukin-6 induces the production of C-reactive protein. Significant differences in interleukin-6 and C-reactive protein levels between hospitalized and nonhospitalized patients despite identical bacterial DNA loads suggest an important role for host factors in disease presentation. Higher interleukin-6 and C-reactive protein levels seem predictive of more severe disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24477856      PMCID: PMC3993112          DOI: 10.1128/CVI.00715-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  19 in total

1.  Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages.

Authors:  Dale Howe; Jeffrey G Shannon; Seth Winfree; David W Dorward; Robert A Heinzen
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

2.  Circulating cytokine balance and activation markers of leucocytes in Q fever.

Authors:  C Capo; N Amirayan; E Ghigo; D Raoult; J Mege
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 3.  [Laboratory diagnosis of acute Q fever].

Authors:  Marjolijn C A Wegdam-Blans; Marrigje N Nabuurs-Franssen; Alphons M Horrevorts; Marcel F Peeters; Peter M Schneeberger; Henk A Bijlmer
Journal:  Ned Tijdschr Geneeskd       Date:  2010

Review 4.  Human C-reactive protein: expression, structure, and function.

Authors:  J E Volanakis
Journal:  Mol Immunol       Date:  2001-08       Impact factor: 4.407

5.  Evaluation of a diagnostic algorithm for acute Q fever in an outbreak setting.

Authors:  Mischa M Jager; Gezina Weers-Pothoff; Mirjam H A Hermans; Jamie C E Meekelenkamp; Jeroen J A Schellekens; Nicole H M Renders; Alexander C A P Leenders; Peter M Schneeberger; Peter C Wever
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

6.  Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans.

Authors:  U Vollmer-Conna; C Fazou; B Cameron; H Li; C Brennan; L Luck; T Davenport; D Wakefield; I Hickie; A Lloyd
Journal:  Psychol Med       Date:  2004-10       Impact factor: 7.723

Review 7.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

8.  Markers of infection in inpatients and outpatients with acute Q-fever.

Authors:  Norbert C J de Wit; Cornelis P C de Jager; Jamie C E Meekelenkamp; Marianne Schoorl; Arianne B van Gageldonk-Lafeber; Alexander C A P Leenders; Ron Kusters; Peter C Wever
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

9.  Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis.

Authors:  Dong Wook Jekarl; So-Young Lee; Jehoon Lee; Yeon-Joon Park; Yonggoo Kim; Jeong Ho Park; Jung Hee Wee; Seung Pill Choi
Journal:  Diagn Microbiol Infect Dis       Date:  2013-02-04       Impact factor: 2.803

10.  Wind in November, Q fever in December.

Authors:  Hervé Tissot-Dupont; Marie-Antoinette Amadei; Meyer Nezri; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2004-07       Impact factor: 6.883

View more
  3 in total

1.  Dysregulation of serum gamma interferon levels in vascular chronic Q Fever patients provides insights into disease pathogenesis.

Authors:  Jeroen L A Pennings; Marjolein N T Kremers; Hennie M Hodemaekers; Julia C J P Hagenaars; Olivier H J Koning; Nicole H M Renders; Mirjam H A Hermans; Arja de Klerk; Daan W Notermans; Peter C Wever; Riny Janssen
Journal:  Clin Vaccine Immunol       Date:  2015-04-29

Review 2.  Fatigue following Acute Q-Fever: A Systematic Literature Review.

Authors:  Gabriella Morroy; Stephan P Keijmel; Corine E Delsing; Gijs Bleijenberg; Miranda Langendam; Aura Timen; Chantal P Bleeker-Rovers
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

3.  Serum C-reactive protein and procalcitonin values in acute Q fever, scrub typhus, and murine typhus.

Authors:  I-Fan Lin; Jiun-Nong Lin; Chia-Ta Tsai; Yu-Ying Wu; Yen-Hsu Chen; Chung-Hsu Lai
Journal:  BMC Infect Dis       Date:  2020-05-12       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.